TNC and inflammatory bowel disease: The results from this study show that tenascin-C has a central role in the etiology of IBD and, whilst further work is required, they provide a platform to investigate the possibility of using tenascin-C neutralizing antibodies to reduce the inflammatory pathology and tissue damage associated with IBD and other inflammatory disorders.